Kanabo Group Plc (LON:KNB – Get Free Report)’s share price reached a new 52-week low during trading on Tuesday . The stock traded as low as GBX 0.92 ($0.01) and last traded at GBX 0.92 ($0.01), with a volume of 217090 shares. The stock had previously closed at GBX 1.06 ($0.01).
Kanabo Group Stock Performance
The company has a 50-day moving average of GBX 1.18 and a 200 day moving average of GBX 1.41. The company has a quick ratio of 24.36, a current ratio of 2.78 and a debt-to-equity ratio of 3.49. The firm has a market capitalization of £6.96 million, a PE ratio of -94.00 and a beta of 3.04.
Insider Buying and Selling
In other Kanabo Group news, insider Ian Mattioli acquired 150,000 shares of the company’s stock in a transaction on Tuesday, August 27th. The stock was acquired at an average price of GBX 1 ($0.01) per share, for a total transaction of £1,500 ($1,947.55). 37.01% of the stock is owned by company insiders.
Kanabo Group Company Profile
Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary Care segments. The company offers The GP Service, an online telehealth platform, that provides patients with video consultations, online prescriptions, and primary care services; and operates Treat It, an online clinic focused on management of chronic pain.
Recommended Stories
- Five stocks we like better than Kanabo Group
- How to Start Investing in Real Estate
- A $1.75 Billion Gamble: Can Lucid Ignite Growth?
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- The Rally in Lockheed Martin and RTX Can Continue: Here’s Why
- 3 Ways To Invest In Coffee, Other Than Drinking It
- 3 Undervalued Technology Stocks With Big Rebound Potential
Receive News & Ratings for Kanabo Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kanabo Group and related companies with MarketBeat.com's FREE daily email newsletter.